Presentations Clinical Update from Phase 1/2 ABILITY Study National Brain Tumor Society's Research Round Table Presentation Medicenna Therapeutics Corp. - Corporate Presentation Q3 2023 Past Events September 30, 2020 at 10:00 AM EDT Medicenna Annual and Special Meeting Go to September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to June 18, 2020 at 1:40 PM EDT Raymond James Human Healthcare Innovation Conference Go to June 9 - June 12, 2020 Spring Virtual Investor Summit (Virtual) Go to May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Current page 12 Page 13 Next page next › Last page last »
September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to
September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to
May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to
